from Na x -positive glial cells are primary steps in this process.
INTRODUCTION
A positive correlation between salt (NaCl) intake and blood pressure (BP) has long been postulated (Intersalt Cooperative Research Group, 1988; Mente et al., 2014) . A battery of experimental and clinical studies using time-controlled sampling have shown that a diet high in salt increases sodium concentrations ([Na + ]) in plasma and the cerebrospinal fluid (CSF) (Adrogué and Madias, 2007; de Wardener et al., 2004; Stocker et al., 2013) . Previous studies using experimental animals revealed that the intraperitoneal (i.p.) and intravenous (i.v.) administration of hypertonic NaCl solutions acutely elevated BP (Fedorova et al., 2000; Frithiof et al., 2007) . Elevations in plasma [NaCl] have been suggested to induce the expansion of the intravascular fluid volume (Gavras and Gavras, 2012) and trigger vasopressin secretion from the pituitary gland into the blood (Henderson and Byron, 2007) , with both leading to BP elevations. Vasopressin induces vasoconstriction by activating V1a receptors expressed in vascular smooth muscle cells (Henderson and Byron, 2007) . In addition to these mechanisms, elevations in plasma and CSF [NaCl] enhance sympathetic nerve activity (SNA), leading to increases in BP (Stocker et al., 2013) . Animal studies demonstrated that the blockade of SNA strongly attenuated the BP elevations induced by a high salt (HS) intake or [Na + ] increases in body fluids (Kawano and Ferrario 1984; Ribeiro et al., 2015 ). An i.v. injection of hypertonic NaCl solution enhanced SNA in human subjects (Farquhar et al., 2006) . Moreover, intracarotid or intracerebroventricular (i.c.v.) infusion of hypertonic NaCl increased BP and changed SNA (Frithiof et al., 2014; Kawano and Ferrario, 1984) . These findings suggest that some monitoring mechanisms for [Na + ]
(and/or [Cl À ]) exist in the brain. The organum vasculosum lamina terminalis (OVLT) was recently proposed as the sensing site of [Na + ] elevations in the brain (Kinsman et al., 2017a (Kinsman et al., , 2017b . However, the molecular mechanisms responsible for [Na + ] sensing to induce sympathetically mediated BP elevations have not yet been elucidated. The OVLT and subfornical organ (SFO) comprise sensory circumventricular organs (sCVOs) devoid of a blood-brain barrier (BBB) (McKinley et al., 2003) . Fenestrated capillaries in the OVLT and SFO facilitate [Na + ] equilibration between plasma and extracellular fluid in the brain. These two loci face the third ventricle and thus are also suitable for monitoring [Na + ] in CSF. Previous studies suggested the indispensable roles of the OVLT in the control of SNA and BP (Kinsman et al., 2017a) : a lesion on the anteroventral third ventricular region (AV3V) encompassing the OVLT was found to impair SNA and BP responses to central hypernatremia (Stocker et al., 2015) . The OVLT has neural connections to the paraventricular nucleus (PVN) of the hypothalamus (McKinley et al., 2003) . Moreover, cardiovascular sympathetic outflow is regulated through PVN neurons that reside in the parvocellular subdivision of the nucleus and innervate the lower brainstem (such as the nucleus of the solitary tract [NTS] and rostral ventrolateral medulla [RVLM] ) and spinal cord (Guyenet, 2006) . The Na x channel is the most-characterized brain [Na + ] sensor and monitors increases in [Na + ] in blood and CSF within the physiological range (Hiyama et al., 2002 (Hiyama et al., , 2013 . Na x is expressed in the lamellar processes of specialized glial cells (astrocytes and ependymal cells) in the OVLT and SFO, in which these glial processes wrap the soma of neurons (Watanabe et al., 2006) . We previously demonstrated that Na x signals were involved in the control of salt and water intakes; Scn7a-knockout (Na x -KO) mice did not stop ingesting salt, even under dehydrated conditions (Watanabe et al., 2000) . We also showed that the SFO is the principal site for sensing [Na + ] in body fluids by Na x to control salt appetite (Hiyama et al., 2004; Matsuda et al., 2017) . Our recent findings suggested that the Na x signal in sCVOs is also involved in water-intake control (Sakuta et al., 2016) . However, possible roles for Na x in BP control have not yet been elucidated.
In the present study, we examined BP and SNA changes in WT and Na x -KO mice in response to [ from Na x -positive glial cells induced the activation of acidsensing ion channel 1a (ASIC1a) in OVLT(/PVN) neurons.
RESULTS

Na x Mediates Salt-Induced BP Elevations through Sympathetic Activation: Chronic High Salt Intake
We compared the effects of mandatory HS ingestion between WT and Na x -KO mice using 2% NaCl, as previously reported in rats and mice by many groups (Choe et al., 2015; Ribeiro et al., 2015; Nicol et al., 2005) : BP elevations were induced by the replacement of drinking water with 2% NaCl (HS ingestion). After HS ingestion for 7 days, [Na + ] levels in blood and CSF similarly increased to $160 mM from $145 mM in both genotypes (Figures 1A and 1B) . HS-ingested WT mice showed significant elevations in MBP without changes in the diurnal cycle ( Figure 1C) . However, the elevations in mean arterial BP (MBP) caused by HS ingestion were not observed in Na x -KO mice ( Figure 1C ): MBP levels were similar throughout the day to those of control conditions without HS ingestion. Accordingly, the 24-hr average of MBP was significantly higher (by $7 mmHg) in HS-ingested WT mice than in Na x -KO mice treated equally ( Figure 1D) ; it is important to note that HS ingestion did not affect the daily locomotor activities of the two mouse strains and that basal BP and the water/Na balance were similar (Figures S1A-S1E).
To assess the contribution of SNA to the difference observed in the MBP between the two genotypes, we examined the effects of the acute blockade of autonomic ganglia with chlorisondamine (CSD). In mice without HS ingestion, an i.p. injection of CSD decreased MBP by $28 mmHg in both genotypes (Figure 1E) . HS-ingested WT mice showed a large reduction in MBP ($41 mmHg) by CSD. In contrast, the reduction in MBP in HS-ingested Na x -KO mice was markedly smaller and at the same level ($28 mmHg) as that of the control condition ( Figure 1E ). (C) Circadian changes in MBP in control and HS-ingested mice. n = 9 each. *p < 0.05, **p < 0.01, ***p < 0.001 (control WT versus HS-ingested WT); # p < 0.05, ## p < 0.01, ### p < 0.001 (HS-ingested WT versus HS-ingested Na x -KO).
(D) Average MBP over a 24-hr period in control and HS-ingested mice. n = 9 each. (E) Changes in MBP after an i.p. injection of chlorisondamine (CSD, a ganglionic blocker, 10 mg/kg body weight), indicating the contribution of the autonomic nervous system to MBP. n = 5 each. ], right) Na solutions under conscious freely moving conditions. The infusion was performed during the time indicated by the horizontal bar. n = 5 each. The value at 0 min was set to zero on the ordinate. (G) Changes in MBP in response to the i.c.v. infusion of hypertonic Na solution in mice pretreated with CSD (20 mg/kg body weight). n = 5 each. (H) Profiles of the CSD-sensitive component (left) and Na x -dependent component (right) in MBP. They were obtained from differences between the fitted curves for MBP data with (G) and without (F, left) CSD, and differences in the fitted curves for MBP data between the two genotypes in (F, left), respectively. In order to fit data, the following equation was used: MBP = P Max /(1 + exp((t 1/2 À t)/a)), where t = time. P Max = 14.20 mmHg (WT without CSD), 6.00 mmHg (Na x -KO without CSD), 4.20 mmHg (WT with CSD), and 5.80 mmHg (Na x -KO with CSD). t 1/2 = 3.80 min (WT with and without CSD) and 4.50 min (Na x -KO with and without CSD). a = 0.55 min. (I) Changes in MBP in response to the i.c.v. infusion of hypertonic Na solution when mice were pretreated with Manning compound (MC, 3 mg/kg body weight). n = 5 each. (J) Changes in MBP in response to the i.c.v. infusion of hypertonic Na solution when mice were pretreated with MC (3 mg/kg body weight) and CSD (20 mg/kg body weight). n = 5 each. (K) Changes in MBP in response to the i.c.v. infusion of hypertonic Na solution when mice were pretreated with MC (3 mg/kg body weight) under anesthesia. n = 6 each. (L) Left: a representative raw record of lumbar SNA just before (0 min) and 10 min after the i.c.v. infusion of hypertonic Na solution. Scale bar, 0.1 s. Right: changes in lumbar SNA in response to the i.c.v. infusion of hypertonic Na solution. n = 6 each. The value at 0 min was set to 100%. CSD and MC were i.p. injected 1 hr before the i.c.v. infusion in (G), (I), (J), (K), and (L). Data are expressed as means ± SEM; ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001, unless otherwise specified. In (F), (G), and (I)-(L), *p < 0.05, **p < 0.01, ***p < 0.001 between genotypes at each time points. Details of statistical analysis for each experiment are shown in Table S2. See also Figures S1 and S2 and Table S1 .
Increases in blood and CSF [Na + ] and the necessity of Na x for the BP and SNA elevations induced by salt retention were also observed in the deoxycorticosterone acetate plus salt (DOCAsalt) hypertension model ( Figures S2A-S2D) , another popular animal model of chronic salt-induced hypertension (Yemane et al., 2010) . Na x Mediates Salt-Induced BP Elevations through Sympathetic Activation: i.p. Infusion of Hypertonic Saline As a method to acutely elevate [Na + ] in body fluids, we examined the effects of an i.p. infusion of hypertonic saline (3 M NaCl, 10 mL/20 g body weight/min for 10 min). [Na + ] levels in blood and CSF were synchronously increased by the i.p. infusion of hypertonic saline in both genotypes and appeared to plateau within 15-30 min after the onset of infusions (165 and 160 mM, respectively: Figure S2E ). In WT mice, a concomitant increase in MBP was observed and reached $15 mmHg 30 min after the start of the i.p. infusion of hypertonic saline (Figures S2F and S2H) ; however, MBP in Na x -KO mice did not show any responses at either time point ( Figures S2F and S2H ). The i.p. infusion of isotonic saline (145 mM NaCl) exerted no effects on MBP in WT or Na x -KO mice. Sympathetic blockade with CSD abolished the MBP response in WT, with no effects being observed in Na x -KO mice (Figures S2G and S2H) . The difference between the two genotypes resultantly disappeared, which indicated the contribution of Na x to sympathetically mediated BP elevations induced by increased [Na + ] in body fluids. Na x Mediates Salt-Induced BP Elevations through Sympathetic Activation: i.c.v. Infusion of Hypertonic Na Solution We attempted to directly stimulate brain Na x from the cerebral ventricles using an i.c.v. infusion of hypertonic Na solution; an artificial CSF infusion containing 450 mM [Na + ] (0.4 mL/min for 10 min) also increased CSF [Na + ] up to $160 mM after 10 min (Table S1 ). The infusion of hypertonic Na solution elevated MBP 3-5 min after the infusion, reaching a plateau within 7-10 min in both genotypes; however, the magnitude of this increase was markedly smaller in Na x -KO mice than in WT mice ($6 mmHg versus $15 mmHg: Figure 1F , left). As a control, the i.c.v. infusion of isotonic Na solution did not change MBP in WT or Na x -KO mice ( Figure 1F , right). Sympathetic blockade with CSD markedly reduced the MBP response in WT but not Na x -KO mice and, resultantly, abolished the difference between the two genotypes ( Figure 1G ). The profile of the CSD-sensitive component ( Figure 1H , left) calculated from differences between the data shown in Figure 1F , left, and Figure 1G indicated that sympathetically mediated BP elevations were absent in Na x -KO mice. In addition, the profile of the Na x -dependent component ( Figure 1H , right) calculated from differences between the two genotypes in Figure 1F , left, was almost consistent with that of the CSD-sensitive component in WT ( Figure 1H , left), again suggesting that Na x drives sympathetically mediated BP elevations.
We then examined the effects of Manning compound (MC), a blocker of vasopressin receptor 1a, because vasopressin induced by an i.c.v. infusion of hypertonic Na solution was shown to contribute to increase in MBP (Iitake et al., 1989) . In WT mice pretreated with MC, MBP gradually increased from 5 min after the i.c.v. infusion, reaching a plateau at $8 mmHg ( Figure 1I ). On the other hand, MBP elevations completely disappeared in Na x -KO mice with the same treatment, indicating that the MBP elevation in Na x -KO mice was caused by vasopressin alone. An additional CSD treatment completely abolished the MBP response in MC-pretreated WT mice, with no effect being observed in Na x -KO mice (Figure 1J) . These results indicate that the Na x signal is used solely for sympathetically mediated BP elevations. The SNAindependent component in the MBP elevation was judged to be vasopressin dependent: this component in the MBP elevation was similar between the two genotypes ( Figure 1G ). It is important to note that vasopressin responses to dehydration in Na x -KO mice were normal in our previous study (Nagakura et al., 2010) .
The BP response in MC-pretreated (vasopressin-blocked) WT mice ( Figure 1I ) was almost consistent with the profile of the CSD-sensitive (sympathetically mediated) component and Na xdependent component ( Figure 1H ). This result indicates that BP elevations under the MC-pretreated condition correspond entirely to the Na x -dependent (sympathetically mediated) component. Therefore, we hereafter pretreated mice with MC before the i.c.v. infusion of hypertonic Na solution. To confirm SNA increases, we directly measured SNA in lumbar sympathetic nerve fibers under anesthesia; the i.c.v. infusion of hypertonic Na solution elevated MBP unalterably in anesthetized mice ( Figure 1K ). After the i.c.v. infusion of hypertonic Na solution, raw lumbar SNA increased in WT, but not in Na x -KO mice ( Figure 1L , left). The time course of changes in lumbar SNA ( Figure 1L , right) was similar to the pattern of the CSD-sensitive component in MBP ( Figures 1H, left) . Collectively, these results clearly indicate that the Na x signal mediates [Na + ]-dependent BP elevations via increase in SNA.
OVLT(/PVN) Neurons Mediate Salt-Induced BP Elevations The SFO and OVLT have neural pathways to the PVN of the hypothalamus, in which presympathetic neurons reside to control SNA (Guyenet, 2006) . Neurons projecting to the PVN were detected in the SFO and OVLT by our retrograde labeling with CTb-488, which are herein referred to as SFO(/PVN) and OVLT(/PVN) neurons, respectively (Figure 2A ). CTb-488-positive OVLT(/PVN) neurons were tightly embedded in Na x -positive glial cells harboring processes extending to the parenchyma (Figure 2A ). Focal lesion experiments demonstrated that the OVLT, but not SFO, plays a role in [Na + ] sensing in CSF by Na x for BP control ( Figures S3A and S3B) , which is consistent with previous findings (Stocker et al., 2015) . SFO(/PVN) and OVLT(/PVN) neurons were both activated by HS ingestion (Figures 2B and 2C) ; however, a difference in neural activities (Fos expression) between the two genotypes was only observed in the OVLT, not in the SFO, again suggesting the contribution of the OVLT to the [Na + ]-dependent control of BP (Figures 2B and 2C) .
To investigate whether OVLT(/PVN) neurons actually drive BP elevations, we performed optogenetic experiments using channelrhodopsin 2 (ChR2), a blue-light-gated cation channel. We injected a highly efficient retrograde gene-transfer lentiviral vector (HiRet) (Kato et al., 2011) carrying double-loxPflanked inverted orientation (DIO)-ChR2-EYFP into the PVN of vesicular glutamate transporter 2 (Vglut2)-Cre or vesicular GABA (g-aminobutyric acid) transporter (Vgat)-Cre mice (Figure S3C, left) . Since most OVLT(/PVN) neurons were Vglut2 positive, not Vgat positive ( Figure S3C ), Vglut2-Cre mice were used in subsequent optogenetic experiments. Cells labeled with EYFP, namely Vglut2-positive neurons projecting to the PVN, appeared to predominantly reside inside the OVLT ( Figure 2D ).
Stimulations with a pulsed blue laser at 5 and 20 Hz rapidly elevated MBP in a pulse-rate-dependent manner ($15 and $30 mmHg, respectively) ( Figure 2E ). At a 5-Hz stimulation, the MBP elevation was similar to that induced by the i.c.v. infusion of hypertonic Na solution. The optical stimulation of the OVLT at 5 Hz immediately increased MBP, and this elevation was maintained during the stimulation; however, when the laser was turned off, MBP returned to the baseline level within 1 min ( Figure 2F , left). As expected, the MBP increase observed with the optical stimulation was completely abolished by the pretreatment with CSD ( Figure 2F , right), indicating that the activation of OVLT(/PVN) neurons actually drives BP elevations through sympathetic nerve activation.
To also examine the effects of the optogenetic inhibition of Vglut2-positive OVLT(/PVN) neurons using a light-activated chloride pump (third-generation Natronomonas halorhodopsin, eNpHR3.0; Gradinaru et al., 2010) , HiRet-DIO-eNpHR3.0-EYFP was injected into the PVN of Vglut2-Cre mice ( Figure 2G ). Optical inhibition expectedly abrogated the MBP increases induced by the i.c.v. infusion of hypertonic Na solution ( Figure 2H ). The expression of eNpHR3.0 itself did not affect the BP response to the i.c.v. infusion of hypertonic Na solution ( Figure 2H , Opt OFF group).
H + Is [Na + ]-Dependently Released from Na x -Positive Glial Cells and Activates OVLT(/PVN) Neurons To elucidate the activation mechanisms of OVLT(/PVN) neurons by Na x signals, firing properties were examined using acute brain slices ( Figure 3A) ; experiments were performed using cellattached patch-clamp techniques in the presence of inhibitors of synaptic transmission. In isotonic Na solution ([Na + ] = 145 mM), the OVLT(/PVN) neurons of both genotypes exhibited continuous firing activity at $1 Hz ( Figure 3B ). When the perfusate was changed to hypertonic Na solution ([Na + ] = 160 mM), the firing rate of OVLT(/PVN) neurons in WT brain slices was upregulated to $3 Hz, but not in Na x -KO slices ( Figure 3B ).
We previously showed that the activation of Na x by an increase in extracellular [Na + ] stimulated anaerobic glycolysis in Na x -positive glial cells in the SFO, which resultantly led to the release of lactate via monocarboxylate transporters (MCTs) (Shimizu et al., 2007) . Lactate functioned as an energy substrate for neighboring inhibitory neurons and upregulated their firing activities, leading to the suppression of neurons encoding salt appetite (Matsuda et al., 2017; Shimizu et al., 2007) . The double immunostaining of Na x and glial fibrillary acidic protein (GFAP) again demonstrated that Na x -positive cells in the OVLT were glial cells ( Figure 3C ). The incubation of OVLT cells in hypertonic Na solutions in vitro markedly enhanced glucose uptake by Na x -positive cells ( Figures 3C and 3D) . Consistently, the incubation of OVLT tissues in hypertonic Na solution markedly enhanced lactate release from the OVLT of WT mice, but not Na x -KO mice ( Figure 3E ).
The specific ablation of GFAP-positive cells using a cytotoxic diphtheria toxin A fragment (dtA) ( Figure 3F ) and the inhibition of lactate transporters (MCTs) by a-cyano-4-hydroxycinnamic acid (a-CHCA) ( Figure 3G ) both significantly reduced lactate release from the OVLT. Consistent with the inhibition of MCTs by a-CHCA, the activation of OVLT(/PVN) neurons by hypertonic Na was abolished by a-CHCA ( Figure 3B ). Sympathetically were colored in yellow. n = 7 each. Data are expressed as means ± SEM, unless otherwise specified. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001. Details of statistical analysis for each experiment are shown in Table S2 . See also Figure S3 . 
ASIC1a Mediates the Na x -Dependent Activation of OVLT(/PVN) Neurons
Previous studies reported that salt-induced BP elevations were blocked by the i.c.v. infusion of benzamil, a broad inhibitor of the epithelial sodium channel/degenerin (ENaC/DEG) superfamily (for example, Huang and Leenen, 2002) . A prior injection of benzamil into the OVLT consistently and completely abolished sympathetically mediated MBP elevations caused by the i.c.v. infusion of hypertonic Na solution in WT mice, whereas no effects were observed in Na x -KO mice ( Figures 5A and 5C ). Therefore, we speculated that ASICs, a benzamil-sensitive H + -gated subgroup in the ENaC/DEG superfamily (Wemmie et al., 2006) , are involved in [Na + ]-dependent elevations in BP.
A pretreatment of the OVLT with psalmotoxin-1 (PcTx1), a specific inhibitor of ASIC1a (Escoubas et al., 2000) , abolished the MBP elevations induced by increases in CSF [Na + ] in WT mice, whereas APETx2, a specific inhibitor of ASIC3 (Diochot et al., 2004) , did not ( Figures 5B and 5C ). ASIC1 expression in OVLT(/PVN) neurons was verified by immunofluorescence staining ( Figure 5D , i). Of note, neurons retrogradely labeled with CTb-488 were detected in the area surrounding the OVLT; however, they were negative for ASIC1 expression ( Figure 5D , ii). We then performed the knockdown of ASIC1 in the OVLT using adeno-associated virus (AAV) vectors carrying artificial microRNA (amiRNA) targeting ASIC1 or LacZ (as control). Infected cells were visualized by immunofluorescent signals of emerald green fluorescent protein (EmGFP) (Figures 5E and S4) . We found that reductions in BP responses were associated with decreased ASIC1 immunoreactivity in the OVLT by ASIC1 amiRNA ( Figure 5F ). Collectively, these results indicated the involvement of ASIC1a in the H + -dependent activation of OVLT(/PVN) neurons. Electrophysiological experiments using acute brain slices further supported our conclusion: the activation of OVLT(/PVN) neurons in response to an increase in extracellular [Na + ] was abolished by benzamil and PcTx1 (Figures 5G and 5H) .
We tested the effects of MitTx, an ASIC1 activator (Bohlen et al., 2011) , in in vivo experiments. Continuous injections of 0.1 and 1.0 mM of MitTx into the OVLT dose-dependently induced MBP elevations in both genotypes (Figures 5I and 5K) . It is important to note that ASIC2 and ASIC3 were not activated by 0.1 mM of MitTx (Bohlen et al., 2011) . The effects of MitTx were expectedly abolished by ganglionic blockade with CSD ( Figures  5J and 5K ).
The Na x Signal Elevates BP through the PVN-RVLM Pathway The SNA increase caused by the activation of OVLT(/PVN) neurons has been suggested to be mediated through the PVN-RVLM pathway (Guyenet, 2006) . In support of this view, PVN perfusate during the time indicated by the horizontal bar. Representative firing activities (left, top), time courses (left, bottom), and summarized data (right) are shown. Summary data are those obtained at 4-5 min, 14-15 min, and 24-25 min. n = 6 each. ### p < 0.001 between genotypes. (C) Left: imaging analysis of glucose (2-NBDG) uptake by dissociated OVLT cells. Cells dissociated from the OVLT of WT mice were subjected to an imaging analysis of glucose uptake using 2-NBDG in 145 or 160 mM [Na + ] solution. After imaging, cells were immunostained with anti-GFAP and anti-Na x antibodies. DIC, differential interference contrast image. Scale bars, 25 mm. Right: summary of glucose uptake by cells expressing both GFAP and Na x (GFAP+, Na x +) and neither (GFAPÀ, Na x À). Glucose uptake in 160 mM Summary data are expressed as means ± SEM. ns, not significant; **p < 0.01, ***p < 0.001. Details of statistical analysis for each experiment are shown in Table S2 . See also Figure S3 . (Figures  6A) . Moreover, RVLM neurons expressing tyrosine hydroxylase (TH) were activated in WT, but not in Na x -KO mice, by HS ingestion (Figures 6B); TH-positive RVLM neurons are known to control spinal sympathetic pre-ganglionic neurons (Burke et al., 2014) . Thus, Na x signals were transmitted through the OVLT-PVN-RVLM neural pathway to activate SNA, which resultantly elevated BP ( Figure 6C ).
DISCUSSION
In the present study, we demonstrated that distinct salt-loading experiments, dietary HS ingestion, the DOCA-salt protocol, and i.p. infusion of hypertonic saline all increased [Na + ] in the blood and CSF of mice (Figures 1 and S2 ). Blood and CSF [Na + ] were strongly associated in animals treated with these application protocols. Acute and chronic increases in [Na + ] (7-10 mM) in body fluids (blood and CSF) both activated the sympathetic nervous system and elevated BP by 10-15 mmHg (Figures 1 and  S2 ). In genetically hypertensive rats (Dahl salt-sensitive rats and spontaneously hypertensive rats), HS intake increased [Na + ] levels in the CSF, which preceded BP elevations (Guo et al., 2015; Huang et al., 2004) . According to a recent study, animals exposed to chronic salt intake since weaning showed increased [Na + ] levels specifically in the CSF as well as BP elevations (Gomes et al., 2017 ] increases in the CSF and blood were both sensed by Na x present in the glial cells (ependymal cells and astrocytes) of the OVLT (see Figure 6C ). When [Na + ] was selectively increased in the CSF by the i.c.v. infusion, the Na x -dependent BP elevation observed was $8 mmHg ( Figure 1H ). This value was smaller than the corresponding value ($12 mmHg) induced by [Na + ] increases in the blood and CSF using other protocols ( Figures 1A-1E and S2) , suggesting that Na x in the OVLT monitors [Na + ] in these two body fluids ( Figure 6C ). The activation of Na x in the OVLT by extracellular [Na + ] increases led to the release of H + ions and lactate through MCTs from Na x -positive cells ( Figures 3E-3G, 4D , and 4E), as well as those in the SFO (Shimizu et al., 2007) . Under dehydrated conditions, lactate was secreted as a gliotransmitter from Na x -positive glial cells in response to [Na + ] increases in order to activate inhibitory neurons in the SFO (Shimizu et al., 2007) : lactate was used as an energy source in GABAergic neurons in the SFO to stimulate metabolic activity for the production of ATP. The resultant increase in [ATP] has been suggested to inhibit ATP-sensitive K + channels and activate inhibitory neurons to suppress salt intake (Shimizu et al., 2007) . In contrast, H + was the signaling substance that stimulated specific OVLT(/PVN) neurons in the OVLT (Figures 4A-4C ). OVLT(/PVN) neurons were activated by H + through ASIC1a activation and transmitted the Na x signal to RVLM neurons to activate SNA, leading to BP elevations. A recent study demonstrated that SNA was increased by the direct infusion of hypertonic NaCl to the OVLT, but not by that of equiosmotic sorbitol (Kinsman et al., 2017b) . The same group showed that some OVLT neurons were activated without a synaptic input when the extracellular [Na + ] concentration was increased in the physiological range (by 2.5-10 mM) (Kinsman et al., 2017a) . Na x is considered to fulfill the criteria of brain [Na + ] sensor because it detects small increases in extracellular [Na + ] (Hiyama et al., 2002 (Hiyama et al., , 2013 . Of note, a recent epidemiological study suggested that polymorphisms in the SCN7A gene encoding Na x were associated with ''essential hypertension'' (Zhang et al., 2015) . Collectively, these findings support our view that information on [Na + ] increases in body fluids sensed by Na x in the OVLT is used for BP control.
The central administration of benzamil, a broad inhibitor for the ENaC/DEG superfamily, including ASICs, was previously reported Summary data are expressed as means ± SEM, unless otherwise specified. ns, not significant; **p < 0.01, ***p < 0.001. Details of statistical analysis for each experiment are shown in Table S2 . to attenuate salt-induced BP elevations (Huang and Leenen, 2002) : benzamil has the strongest affinity for ENaCs (Kellenberger and Schild, 2002) . We verified that benzamil and PcTx1 both consistently inhibited the activity of OVLT(/PVN) neurons (Figures 5G and 5H ). In the present study, we demonstrated that ASIC1a in the OVLT was involved in the control of sympathetically mediated BP elevations. However, it is important to note that the present results do not exclude the possibility that ENaCs are involved in salt-sensitive hypertension in other brain regions. For example, Nedd4-2 (neural precursor cell-expressed and developmentally downregulated protein 4-2)-KO mice associated with salt-sensitive hypertension showed increased expression levels of ENaCs in the choroid plexus and some brain regions (including the PVN and supraoptic nucleus [SON], but not the SFO or OVLT) (Van Huysse et al., 2012) . ASIC1a is produced from one of the alternatively spliced transcripts of the ASIC1 gene and exhibits higher sensitivity to H + than ASIC1b or other ASIC members (Wemmie et al., 2006) . Thus, ASIC1a alone detects mild reductions in extracellular pH to 7.0 and drives neuronal excitation (Ziemann et al., 2008) . In addition, the H + -evoked current of ASIC1a is known to be enhanced by several modulators, including lactate and arachidonic acid (AA) (Immke and McCleskey, 2001; Smith et al., 2007) . As expected, lactate enhanced the H + -induced activation of OVLT(/PVN) neurons ( Figure 4F) . Notably, the Na x signal may lead to the production of epoxyeicosatrienoic acids (EETs) in the OVLT through the activation of the AA cascade (Sakuta et al., 2016) . Since treatments with hyperosmotic mannitol solution did not activate pH-sensitive OVLT(/PVN) neurons ( Figure 4G ), osmotic changes (induced by hypertonic Na solution) did not appear to activate ASIC1a-positive OVLT(/PVN) neurons.
The PVN harbors magnocellular and parvocellular neurons that secrete vasopressin and mediate sympathetic control, respectively (Badoer, 2001; Swanson and Sawchenko, 1983) . BP elevations by the optogenetic activation of Vglut2-positive OVLT(/PVN) neurons and those by a direct injection of MitTx, an ASIC1 activator, into the OVLT were both completely abolished by the blockade of SNA ( Figures  2F and 5K) . OVLT(/PVN) neurons activated by the Na x signal may selectively stimulate parvocellular neurons in the PVN. On the other hand, the vasopressin-dependent component in BP elevations was similar between WT and Na x -KO mice (Figure 1G) . This is consistent with our previous finding showing that Na x -KO mice exhibited normal vasopressin release under dehydrated conditions (Nagakura et al., 2010) . Osmosensing neurons in the OVLT have been postulated to have connections to magnocellular neurons in the SON and PVN for controlling vasopressin secretion (Bourque, 2008) . These findings indicate that osmolality-dependent (or Na x -independent, but [Na + ]-dependent) OVLT neurons are involved in the control of vasopressin secretion.
Our results clearly indicated that the SFO was not the primary sensing site for [Na + ]-dependent SNA control ( Figures 2B and  S3B) . However, the optogenetic activation of glutamatergic neurons in the SFO reportedly elevated BP (Leib et al., 2017) . SFO lesions have been shown to attenuate sympathetically mediated BP elevations induced by blood-derived angiotensin II (Hendel and Collister, 2005) . Thus, the SFO appears to be involved in the control of SNA and BP by detecting circulating angiotensin II. A recent study also reported that adenylate cyclase-activating polypeptide 1 (Adcyap1)-positive neurons in the median preoptic nucleus (MnPO) were activated by an i.p. injection of hypertonic saline and caused BP elevations (Leib et al., 2017) . The MnPO is located dorsocaudally to the OVLT within the AV3V region and receives neural inputs from the OVLT. A small number of MnPO(/PVN) neurons were found in the MnPO ( Figure S5A ), and ASIC1 expression was detected in some of these neurons ( Figure S5B) ; however, Na x was not present in the MnPO (Figure S5C ), as we previously reported (Watanabe et al., 2000; Matsumoto et al., 2015) . The Table S2 . See also Figures S4 and S5 .
MnPO has a normal BBB, and a direct injection of hypertonic NaCl solution into an area dorsal to the OVLT, in which the MnPO is located, did not affect BP (Kinsman et al., 2017a) . These findings strongly suggest that the MnPO is not the primary sensing site for [Na + ]; however, we cannot exclude the possibility that a portion of the Na x signal sensed in the OVLT is relayed through MnPO(/PVN) neurons.
Abundant evidence from epidemiological and interventional studies has established heterogeneity in the BP responses of humans to alterations in salt intake, termed salt sensitivity (Weinberger, 1996) . Although salt sensitivity is mostly related to and associated with the ability to excrete excess salt via the kidneys, it is practically affected by a number of mechanisms, including epigenetic changes and immune responses (Gluckman and activation. The OVLT-PVN-RVLM neural pathway is then activated and elevates BP through increases in SNA. Summary data are expressed as medians with interquartile range. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001. Details of statistical analysis for each experiment are shown in Table S2 . Hanson, 2004; Wenzel et al., 2016) : the ''developmental origins of health and disease'' (DOHaD) model postulated that the risk of suffering chronic diseases depends in part on environmental influences acting early on life. It was also shown that a HS challenge in humans affected gut microbiome, induced T helper 17 cells to drive autoimmunity, and increased BP (Wilck et al., 2017) . Macrophages reportedly attenuate salt-dependent BP elevations by a vascular endothelial growth factor-C-dependent buffering mechanism (Machnik et al., 2009) . Thus, salt sensitivity in humans needs to be recognized as a complex trait induced by the combination of salt and various factors (Elijovich et al., 2016; Schiffrin, 2018) .
As the mechanism of salt-induced hypertension, early theories simply centered on the expansion of the blood volume by increased sodium and water retention. However, strong evidence now suggests that salt-sensitive hypertension is mainly attributed to renal dysfunction, vascular abnormalities, and activation of the sympathetic nervous system. Our present study clearly demonstrates that the brain [Na + ] sensor-deficient Na x -KO mice do not exhibit sympathetically mediated BP elevations, even when [Na + ] in the blood and CSF increases to $160 mM. Our results may provide novel neural therapeutic targets and encourage the future potential for treating a saltsensitive phenotype in humans.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All experimental protocols with animals were reviewed and approved by The Institutional Animal Care and Use Committee of the National Institutes of Natural Sciences, Japan (approval numbers 14A149, 15A164, 16A25, 17A006, and 18A018). Male wild-type (C57BL/6J, CLEA Japan), homozygous Scn7a-knockout (Na x -KO; Watanabe et al., 2000) , heterozygous Slc17a6-ires-Cre (Vglut2-Cre) (Vong et al., 2011 ) (Jackson Labs stock #016963), heterozygous Slc32a1-ires-Cre (Vgat-Cre) (Vong et al., 2011 ) (Jackson Labs stock #016962), and heterozygous hGFAP-CreER T2 (Ganat et al., 2006) mice at 8 to 20 weeks of age were used. All mice used in these studies were on the C57BL/6J background. Mice were maintained in a temperature-controlled room with a 12-hr light-dark cycle (lights on at 8:00 a.m.) and were allowed free access to food and pure water. We confirmed that Na x -KO mice showed typical patterns in daily systolic, diastolic, and mean arterial BP (MBP) under normal conditions ( Figure S1A ). MBP showed a diurnal pattern with two peaks, as previously reported (Combe et al., 2016) . In the case of HS ingestion, drinking water was replaced with saline containing 2% of NaCl for 7 days. Salt intake and Na excretion amounts were similar between the two genotypes before and 7 days after HS ingestion (Figures S1C-S1E) .
In order to produce the deoxycorticosterone acetate plus salt (DOCA-salt) hypertension model, mice were anesthetized by isoflurane inhalation and then subcutaneously implanted with a 50-mg pellet of DOCA (21-day release; Innovative Research of America) or underwent a sham operation. Mice that underwent the sham operation were maintained with free access to food and pure water (Control group). Mice implanted with DOCA were maintained with free access to food and saline containing 0.9% of NaCl for 20 days (DOCA-salt group).
METHOD DETAILS Experimental Design
Homozygous Na x -KO mice and WT littermates were used in the experiments for comparison. Multiple independent experiments were carried out using several sample replicates as detailed in the figure legends. The samples were processed in a random order. Experiments were not blinded to sample identity but this information was not considered until the data analysis. Data analysis was automated, except for the imaging analysis of c-Fos. No outliners were excluded from analysis, except for mice in that mis-injections in the brain were revealed.
Reagents
Among the drugs used in experiments, chlorisondamine diiodide (CSD), kynurenic acid, bicuculline, and tetrodotoxin (TTX) were obtained from Tocris; psalmotoxin-1, APETx2, and MitTx were from Alomone Lab; cholera toxin subunit b, Alexa Fluor 488 conjugate and 555 conjugate (CTb-488 and CTb-555), and 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2deoxyglucose (2-NBDG) were from Thermo Fisher Scientific. All other reagents including [b-mercapto-b (Manning compound, MC) , tamoxifen, and a-cyano-4-hydroxycinnamic acid (a-CHCA) were from Sigma-Aldrich. 
Recombinant viral vectors
Serotype 5 and DJ-type recombinant adeno-associated viruses (AAV) and a highly efficient retrograde gene-transfer lentivirus (HiRet) (Kato et al., 2011) , a pseudotyped lentiviral vector with the rabies virus glycoprotein, were used for gene transfer into the mouse brain (> 1.0 3 10 10 genomic copies (GC)/mL). HiRet-MSCV-DIO-ChR2(H134R)-EYFP-WPRE and HiRet-MSCV-DIO-eNpHR3.0-EYFP-WPRE were used to induce the Credependent expression of ChR2(H134R) or eNpHR3.0 for optogenetic experiments. In order to construct HiRet-MSCV-DIOeNpHR3.0-EYFP-WPRE, pAAV-Ef1a-DIO-eNpHR 3.0-EYFP was used: the latter was a gift from Karl Deisseroth (Addgene plasmid #26966).
AAV-Ef1a-mCherry-FLEX-dtA (AAV-mCherry-DIO-dtA) vectors (Wu et al., 2014) were serotyped with AAV5 coat proteins and packaged by the viral vector core at the University of North Carolina (6 3 10 12 viral particles/mL). AAV-mCherry-DIO-dtA was used for the deletion of astrocytes (see below). AAV vectors carrying artificial microRNA (AAV-Ef1a-EmGFP-WPRE-LacZ amiRNA and AAV-Ef1a-EmGFP-WPRE-ASIC1 amiRNA) were used for in vivo knockdown experiments. The following oligonucleotide DNA pairs were annealed and cloned into the pcDNA6.2-GW/EmGFP-miR vector (Invitrogen, Carlsbad, CA, USA) ], CSF was collected from the cisterna magna, as previously described with minor modifications (Liu and Duff, 2008) . Mice were anesthetized with isoflurane and placed in a stereotactic frame (Narishige). After exposing the cisterna magna, an empty glass needle (tip diameter of approximately 0.5 mm) was inserted to collect the CSF by capillary action. Immediately after collection, CSF [Na + ] was evaluated with Fingraph (Otsuka Pharmaceutical).
Measurement of BP
A telemetry system (Dataquest ART, Data Science International) was used to measure BP in conscious freely moving mice. The sensor tip of the telemetry probe (HD-X11, Data Science International) was placed into the left carotid artery under anesthesia with sodium pentobarbital (50 mg/kg body weight) intraperitoneally (i.p.) injected more than 1 week before the start of experiments. After recording, MBP data were obtained by averaging over 1-min periods, and in the case of analyzing 24-hr circadian changes ( Figures 1C and S1A ), MBP data were averaged over 1-hr periods.
In the measurement of BP in anesthetized mice, a Millar catheter (model SPR-671, Millar Instruments) was placed into the left carotid artery under anesthesia with urethane (1.0-1.3 g/kg body weight, i.p.). Rectal temperatures were maintained at 37.0-37.5 C using a heating pad with a thermometer. After stabilization for 1 hr from the end of surgery, recordings were started. BP data were collected at 0.1 kHz using a data-recording unit (PowerLab26T, AD Instruments), and analyzed using LabChart software (AD Instruments). After recording, MBP raw data were averaged over 1-min periods; in the case of optogenetic experiments, MBP data were averaged over 1 s periods.
The contribution of the autonomic nervous system to BP in conscious mice was assessed using an injection of CSD (10 mg/kg body weight, i.p.) into mice implanted with the telemetry probe ( Figure 1E ). CSD acutely blocks synaptic transmission in autonomic ganglia, including sympathetic ganglia, by inhibiting nicotinic acetylcholine receptors, and, thus, the i.p. injection of CSD immediately (within 5 min) causes large BP reductions. We performed the i.p. injection of CSD after confirming stable MBP. After the experiment, changes in MBP from the baseline to the nadir were calculated. Baseline MBP was calculated by averaging 5 min of MBP just before the i.p. injection of CSD. Nadir MBP was assessed by averaging MBP during the 2 min that exhibited the lowest value. Experiments were performed between 10:00 and 13:00.
In experiments for Figures S2C and S2D , a non-invasive tail-cuff system (BP-98A; Softron, Tokyo, Japan) was used to measure BP. Briefly, mice were placed in a holder to prevent movement and warmed at 37 C. A tail-cuff was then placed at the root of the tail, and systolic BP was measured 10-15 times and averaged. A set of measurements was finished within 10 min. Preceding actual data collection, all mice were acclimatized to the measurement by performing more than 7 sets of measurements (1 set/day). When mice began to walk into the holder, they were judged to be completely acclimated. To minimize the influence of circadian rhythms, BP measurements were performed between 10:00 and 12:00.
Measurement of locomotor activity
A telemetry system (Dataquest ART, Data Science International) with telemetry probes (HD-X11, Data Science International) was used to measure locomotor activity in conscious freely moving mice. The experimental procedure was the same as the BP measurements described above. After recording, activity counts were summed at 1-hr intervals.
Analysis of salt and water metabolism
In order to assess salt and water metabolism, mice were maintained in metabolic cages (Columbus Instruments). Drinking volumes (water or 2% NaCl) and food consumption in 24 hr were measured, and 24-hr urine samples were collected. In order to calculate 24-hr urinary Na + excretion, urinary Na + concentrations were measured using an i-STAT analyzer with an i-STAT 6+ cartridge; if necessary, urine was diluted with deionized water.
I.p. infusion I.p. infusions of isotonic saline (145 mM NaCl) and hypertonic saline (3M NaCl) were performed using a 27-G needle connected to a microsyringe pump (Micro4, World Precision Instruments). Infusions were performed for 10 min at a speed of 10 mL/20 g body weight/min. The tip of the needle was inserted into the abdominal cavity 1 hr before the infusion. In some cases, the i.p. pretreatment with CSD (a ganglionic blocker, 20 mg/kg body weight) was performed 1 hr before the experiment.
Brain surgery
Brain surgery was performed as previously described (Hiyama et al., 2004; Matsuda et al., 2017) with minor modifications. Mice were anesthetized with sodium pentobarbital (50 mg/kg body weight, i.p.) and placed in a stereotactic frame (Narishige). After exposing the skull via a small incision, a small hole was drilled for cannula implantation, injections, or focal lesions.
In order to implant a 26-G guide cannula for intracerebroventricular (i.c.v.) infusions, a guide cannula (C315G, Plastics One or homemade guide cannula) was stereotaxically positioned at the lateral ventricle (antero-posterior, À0.5 mm; lateral, +1.0 mm; ventral, 2.0 mm; relative to the bregma). The guide cannula was fixed to the skull with two anchoring screws and dental cement.
In the case of retrograde labeling with dyes, a glass needle filled with PBS containing 1.0 mg/mL of CTb-488 or CTb-555 was positioned at the RVLM (antero-posterior, À6.8 mm; lateral, +1.1 mm; ventral, 5.9 mm; relative to the bregma) or bilateral PVN (anteroposterior, À0.8 mm; lateral, ± 0.2 mm; ventral, 5.0 mm; relative to the bregma). An injection was performed using a microsyringe pump (Micro4, World Precision Instruments) at a speed of 100 nL/min for 5 min into the RVLM or 50 nL/min for 2 min into the PVN. After the completion of surgery, animals were allowed to recover for more than 7 days and then used.
The procedure used for the virus injection was similar to that for the injection of retrograde tracers described above. The virus was injected into the bilateral PVN or OVLT at a speed of 100 nL/min for 10 or 2.5 min, respectively. More than 4 weeks after the virus injection, animals were used in experiments. Mice for optogenetic experiments were implanted with a 20-G guide cannula (C311G; Plastics One) more than 2 weeks after the virus injection. The tip of the guide cannula was set to just above the OVLT (antero-posterior, +0.7 mm; lateral, ± 0.0 mm; ventral, 4.5 mm; relative to the bregma).
In order to induce electrolytic lesions, a tungsten monopolar electrode (80-100 kOhm resistance and tip diameter of $5 mm; Unique Medical) was inserted into the SFO (antero-posterior, À0.6 mm; lateral, ± 0.0 mm; ventral, 2.5 mm; relative to the bregma) or OVLT (antero-posterior, +0.7 mm; lateral, ± 0.0 mm; ventral, 5.0 mm; relative to the bregma). A positive current (0.5 mA) was passed for 20 s from a current source (53500, Ugo Basile). After the completion of surgery, animals were allowed to recover for more than 7 days, and the implantation of a guide cannula for i.c.v. infusions was then performed (as described above). After experiments had been completed, brains were sectioned at a thickness of 100 mm in order to validate lesions under a microscope (Biozero, Keyence) equipped with a 2 3 objective.
I.c.v. infusion I.c.v. infusions were performed using 33-G internal cannulas (Plastics One) connected to a syringe pump (ESP-64; Eicom) for 10 min at a speed of 0.4 mL/min. Modified Ringer's solution containing (in mM): 140 NaCl, 2.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, 10 glucose, and 5 NaOH (pH 7.4 with HCl), was used as isotonic Na solution (145 mM [Na + ]), and hypertonic Na solutions (300, 450, and 900 mM [Na + ]) were prepared by adding an appropriate volume of NaCl to isotonic Na solution. In some cases, the i.p. pretreatment with MC (a specific antagonist of vasopressin receptor 1a, 3 mg/kg body weight) and/or CSD (a ganglionic blocker, 20 mg/kg body weight) was performed 1 hr before the i.c.v. infusions.
Recording of SNA Lumbar SNA was measured as described previously (Ling et al., 1998) with minor modifications. Mice were anesthetized by urethane (1.0-1.3 g/kg body weight, i.p.) and rectal temperatures were maintained at 37.0 C-37.5 C using a heating pad with a thermometer. The left lumbar sympathetic nerve fiber was exposed by a retroperitoneal approach, and a pair of platinum electrodes (Unique Medical) were attached to the nerve fiber. The electrodes and nerve fiber were fixed with silicon gel (KWIK-CAST, World Precision Instruments) to avoid dehydration. Nerve signals amplified 10,000-fold by an amplifier (DAM-80, World Precision Instruments) were recorded using PowerLab26T at 4 kHz. After stabilization for more than 1 hr, i.c.v. infusions were initiated. MC was injected (3 mg/kg body weight, i.p.) 1 hr before the i.c.v. infusion. After the end of the experiments, animals were euthanized by an excess of anesthetic. Recorded nerve signals were filtered with software (Chart, AD Instruments) at low-and high-frequency cut-offs of 100 and 1,000 Hz, respectively. In the analysis of changes in lumbar SNA, recorded nerve signals were rectified and summed at 1-min intervals, and the postmortem value was subtracted as background noise. Nerve activity just before the start of the i.c.v. infusion was set as 100%, and percentile changes from 100% were shown as % changes in lumbar SNA.
Immunohistochemistry
Mice were transcardially perfused under deep anesthesia, first with PBS and then with 20% neutralized formalin. Brains were carefully removed and further fixed for 48 hr at 4 C. Brains were cut coronally with a microslicer (VT1000S, Leica Microsystems) or cryostat (CM3050S, Leica Microsystems) at a thickness of 50 mm. Regarding the dissection using the cryostat, brains were infiltrated with a graded sucrose series and then embedded in OCT compound (Sakura, Tokyo, Japan).
After blocking with blocking buffer containing 5% normal donkey serum and 0.1% Triton X-100 in PBS at room temperature for 1 hr, brain sections were incubated with primary antibodies at 4 C for 2 days and then washed twice in PBS. Sections were reacted with secondary antibodies at 4 C for 1 day. The primary antibodies used in the present study were as follows: anti-Na x (1:2000) (Matsumoto et al., 2015) , anti-GFP (1:1,000, 04404-84, Nacalai Tesque), anti-ASIC1 (1:200, ASC-014, Alomone Lab), anti-c-Fos (1:500, sc-52G, Santa Cruz Biotechnology), and anti-TH (1:5,000, AB152, Millipore). Brain sections were mounted on slides, and z stack images were captured on a Zeiss LSM 710 confocal microscope or Leica TCS SP8 confocal microscope with Leica HyD hybrid detectors. The specificity of the anti-Na x antibody was validated by using the Na x -KO mice described in our previous study (Matsumoto et al., 2015) . The specificity of the anti-ASIC1 antibody was validated using knockdown experiments ( Figure 5E ).
Optogenetic experiments
Regarding in vivo photoillumination, laser light was delivered through a plastic optic fiber connected to a blue light laser (445 nm, 1,000 mW, CW; KaLaser) or yellow light laser (577 nm, 3,000 mW, CW; Genesis Taipan 577, Coherent). In order to achieve the optical stimulation of ChR2, a pulsed blue light laser at frequencies between 1 and 20 Hz was used. Continuous illumination with yellow laser light was performed for the optical inhibition with eNpHR3.0. Laser output was maintained at 5-10 mW/mm 2 , as measured at the tip of the fiber. The optical power of light in the OVLT was estimated using the online brain tissue light transmission calculator available at http://web.stanford.edu/group/dlab/optogenetics/. In our experiments, the distance from the optical fiber tip to the target tissue was set at 500 mm, and the expected optical power was 1.20-3.64 mW/mm 2 .
In vitro electrophysiology in OVLT slices
In vitro electrophysiological experiments were performed as reported (Hiyama et al., 2013) with minor modifications. CTb-555 was injected bilaterally into the PVN at least 1 week before recordings. Brains were quickly removed and submerged in ice-cold sucrose Ringer's solution containing (in mM): 260 sucrose, 2.5 KCl, 10 MgSO 4 , 0.5 CaCl 2 , 5 HEPES, 10 glucose, and 5 NaOH, bubbled with 100% O 2 (pH 7.4 with HCl) for 5-10 min. Slices were cut with a microslicer (Pro 7, Dosaka EM) at a thickness of 350 mm and then preincubated with modified Ringer's solution bubbled with 100% O 2 at room temperature for more than 1 hr. Slices were then mounted in a recording chamber on an upright microscope (BX61WI, Olympus) and continuously perfused with modified Ringer's solution bubbled with 100% O 2 . NaCl or HCl was added to change [Na + ] or pH in modified Ringer's solution.
All recording solutions contained kynurenic acid (1 mM) and bicuculline (30 mM). In analyses of firing frequencies, cell-attached configurations were obtained in CTb-555-labeled neurons. All recordings were made at 33-36 C. Patch pipettes prepared from borosilicate glass capillaries were filled with pipette solution containing (in mM): 140 K gluconate, 10 KCl, 2 MgCl 2 , 0.2 EGTA, 2 Na 2 ATP, 10 HEPES, and 0.1 spermine (pH 7.4 with HCl). The resistance of the electrodes was 3-7 MU in Ringer's solution. Data were acquired using Axopatch 200B patch-clamp amplifiers (Axon Instruments) with the software pCLAMP and analyzed with the software Clampfit (Axon Instruments).
Glucose imaging of dissociated OVLT cells
The dissociation of cells and glucose imaging were performed as described previously (Shimizu et al., 2007) . Briefly, WT and Na x -KO mice were deeply anesthetized with diethyl ether and decapitated. The OVLT was then excised from the brain. Cells were isolated and plated on glass-bottomed dishes (Matsunami Glass) coated with Cell-tak (BD Biosciences) and incubated in DMEM containing 10% FCS in a humidity-controlled incubator gassed with 5% CO 2 at 37 C for 3 hr. Cells were then incubated with 500 mM of 2-NBDG at 37 C for 10 min. After the application of 2-NBDG to 160 mM [Na + ] solution at 37 C, the fluorescence intensity of cells gradually increased with time, at least until 30 min. Cells were then washed five times with 145 mM [Na + ] solution. The fluorescence of cells (and background) was assessed using a fluorescence microscope (IX71, Olympus) with barrier (wavelength 536 ± 40 nm, GFP-3035B, Semrock, Rochester, NY) and excitation (wavelength 488 ± 10 nm, C7773, Hamamatsu Photonics) filters.
Targeted ablation of glial cells in the OVLT AAV-mCherry-DIO-dtA was injected into the OVLT of hGFAP-CreER T2 or WT mice as described above. Three weeks after the AAV injection, mice were administered tamoxifen twice a day (100 mg/kgbw, i.p.) for 5 d to excise loxP sites in AAV by Cre recombination. Tamoxifen was dissolved in sunflower oil at a final concentration of 10 mg/mL at 37 C, and then filter-sterilized and stored at 4 C for up to 7 d in the dark. One week after the completion of the tamoxifen treatments, brains were used for lactate measurements and immunohistochemistry. More than $90% of Na x -positive cells were resultantly eliminated in the OVLT of hGFAP-CreER T2 mice, relative to WT mice receiving the same treatment.
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Measurement of lactate concentrations OVLTs dissected from brains (n = 15 mice each) were divided into 5 parts and incubated in 0.5 mL of modified Ringer solution containing 1 mM TTX at 37 C for 24 hr. Solutions containing OVLTs were centrifuged at 9,200 3 g for 5 min and supernatants were used for measurements. The lactate concentrations of the supernatants were measured by i-STAT.
Imaging analysis of extracellular pH in OVLT tissue Acute brain slices containing the OVLT were prepared as described above. Slices were immediately placed in an incubating solution bubbled with 100% O 2 and incubated at 25 C for 10-30 min. The solutions contained (in mM): 140 NaCl, 2.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 0.5 HEPES, 10 Sucrose, 10 glucose, and 5 NaOH (pH 7.4 with HCl). The solution was changed to another solution containing 2 0 ,7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF acid, Thermo Fisher; 200 mM), a membrane-impermeable pH-dependent fluorescent dye, and incubated at 37 C for 20 min. During the incubation, fluorescent images were taken with a disc confocal unit (DSU system, Olympus) attached to an upright microscope. The fluorescent ratio was monitored at excitation wavelengths of 438 and 512 nm using a LED light source (Light Engine SPECTRA X, Lumencor). In order to change extracellular [Na + ], the imaging solution containing hypertonic Na was slowly added to the imaging chamber.
Direct injection of drugs into the OVLT Regarding drug injections into the OVLT during BP recordings, mice were placed in a stereotactic frame after the implantation of a Millar catheter, as described above. When the OVLT injection and i.c.v. infusion were performed together ( Figures 3H, 5A , and 5B), a guide cannula for i.c.v. infusions was initially implanted, as described above. A small hole was then drilled, and a glass needle filled with modified Ringer's solution containing the drug was positioned in the OVLT (antero-posterior, +0.7 mm; lateral, ± 0.0 mm; ventral, 5.0 mm; relative to the bregma). Injections of benzamil, PcTx1, and APETx2 were started $30 min before the onset of the i.c.v. infusion using Micro4 at a speed of 100 nL/min for 5 min. In the case of a-CHCA, the continuous injection was started 15 min before the onset of the i.c.v. infusion: during the first 5 min, the injection speed was set at 100 nL/min and was then continued at 10 nL/min until the end of the i.c.v. infusion. The injection of MitTx was performed at a speed of 100 nL/min for 5 min under conditions without i.c.v. infusions. In order to confirm the position of the drug injection, fluorescent latex beads (FluoSpheres, Thermo Fisher Scientific) were injected at the end of experiments. Brains were sectioned at a thickness of 100 mm and the fluorescence of beads was assessed using Biozero with a 2 3 objective.
QUANTIFICATION AND STATISTICAL ANALYSIS
The normality of the data was initially tested by the Shapiro-Wilk test. When normality was not rejected, data were summarized using means ± SEM. The effects of a single or two factors were tested using a one-way or two-way analysis of variance (ANOVA). All repeated-measurements were analyzed using a repeated-measures (RM) ANOVA with Greenhouse-Geisser's correction of the degree of freedom. When normality was rejected, the nonparametric Kruskal-Wallis ANOVA was employed, and medians with interquartile range (IQR) were shown.
Pairwise comparisons were based on paired or unpaired Student's t test, or non-parametric Mann-Whitney U or Wilcoxon signedrank test. These were also applied as a post hoc exploratory analysis when a particular (global) test in ANOVA was significant. All tests were two-sided. Details of the statistical analysis for each experiment are shown in Table S2 . All statistical analyses were preformed using Origin Pro 2017 software (OriginLab Corporation). p < 0.05 was considered to be significant in all experiments.
In the MBP changes in a 24-hr period ( Figure 1C ), a two-way RM ANOVA detected a significant interaction between the group and time (p = 0.006). This interaction was considered due to a differential MBP profile in the HS/WT group; however, the interaction was quantitative, not qualitative. We then employed the analysis based on summary MBP values over the whole periods of the light and dark, namely, 24-hr MBP ( Figure 1D ).
